|1.||Gong, Hao: 2 articles (01/2010 - 01/2010)|
|2.||Lu, Sangwei: 2 articles (01/2010 - 01/2010)|
|3.||Vu, Gia-Phong: 2 articles (01/2010 - 01/2010)|
|4.||Yang, Edward: 2 articles (01/2010 - 01/2010)|
|5.||Liu, Fenyong: 2 articles (01/2010 - 01/2010)|
|6.||Toth, Stefan: 1 article (10/2015)|
|7.||Ciccocioppo, Rachele: 1 article (10/2015)|
|8.||Jonecova, Zuzana: 1 article (10/2015)|
|9.||Kruzliak, Peter: 1 article (10/2015)|
|10.||Maretta, Milan: 1 article (10/2015)|
04/15/1997 - "In a final study directly comparing L8A4 labeled using SIPC and TCB, similar tumor levels were obtained (SIPC, 33.7 +/- 6.1% injected dose/g at 24 h; TCB, 37.8 +/- 6.7% injected dose/g at 24 h); however, tumor-to-tissue ratios for the liver, spleen, and kidneys were 3 times higher with SIPC at later time points. "
10/30/2011 - "In addition, in-vivo sIPC immunization induced significant protection (p<0.01) against subsequent tumor challenge. "
06/01/1999 - "These very promising effects, obtained both at higher and lower tumor drug concentrations, clearly demonstrate the potential phototherapeutical activity of the newly synthesized SiPc."
10/01/1993 - "Using SIPC, thyroid uptake was quite low, decreasing from 0.3% at day 1 to 0.05% at day 8. Tumor uptake reached 46 +/- 11% injected dose/g at day 1 but declined gradually thereafter. "
06/01/1999 - "U87MG.deltaEGFR tumor xenografts, animals received intratumoral or i.v. infusions of paired-label [125I]SIPC-MR1(scFv) and [131I]SIPC-anti-Tac(scFv) as a control. "
|2.||Melanoma (Melanoma, Malignant)
01/01/2010 - "Furthermore, immuno-detection showed substantial expression of SipA and SipC but not SopB in the late phase of infection in macrophages and in the spleen of infected mice. "
09/01/2002 - "typhimurium pathogenicity island 1. A SipC-specific T cell response was induced by infection with either the C5 wild type or attenuated SL3261 vaccine strain of S. "
01/01/2010 - "These results suggest a possible role of SipC and other regulated proteins in supporting survival and replication of Salmonella under oxidative stress and during its systemic infection in vivo."
01/01/1998 - "Pain related to catheter complications (6%, p<0,0002), local infection (1.4%, p=0.02) and obstruction (1.4%, p=0.02) were significantly higher in SIPC. "
|4.||Salmonella Infections (Salmonellosis)
01/01/2010 - "Our results also provide the first direct evidence that SipC is highly expressed in the spleen at late stage of salmonellosis in vivo. "
01/01/2010 - "We have constructed recombinant Salmonella strains that contain a FLAG epitope inserted in-frame to genes invJ, prgJ, sipC, sipD, sopA and sopB, and investigated the expression of the tagged proteins both in vitro and in vivo during murine salmonellosis. "
|5.||Lymphedema (Milroy Disease)
08/01/2010 - "Participants included 40 lower limb lymphedema patients who underwent High Pressure SIPC for a period of 48 hrs. "
08/01/2010 - "Serum Lipid Changes after Short Term SIPC Therapy for Lower Limb Lymphedema."
09/01/2001 - "Sequential Intermittent Pneumatic Compression (SIPC) is an accepted method for treatment of peripheral lymphedema. "
09/01/2001 - "Alternatively, SIPC reduced lymphedema by decreasing blood capillary filtration (lymph formation) rather than by accelerating lymph return thereby restoring the balance in lymph kinetics responsible for edema in the first place."
09/01/2001 - "This prospective study evaluated the effect in 11 patients of a single session of SIPC on both lymphedema volume of the leg and isotope lymphography (99Tc dextran) before SIPC (control) and 48 hours later after a 3 hour session of SIPC. "
|2.||1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenylglycoluril
|3.||Proteins (Proteins, Gene)
|6.||High-Molecular-Weight Kininogen (Kininogen, High Molecular Weight)
|7.||Photosensitizing Agents (Photosensitizers)
|1.||Heterologous Transplantation (Xenotransplantation)
|4.||Photochemotherapy (Photodynamic Therapy)